Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Day One Biopharmaceuticals (DAWN) Tax Provisions (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Tax Provisions for 2 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • For Q4 2025, Tax Provisions fell 69.27% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 72.17%, while the annual FY2025 figure was $2.0 million, 72.17% down from the prior year.
  • Tax Provisions was $2.0 million for Q4 2025 at Day One Biopharmaceuticals, down from $6.4 million in the prior quarter.
  • The five-year high for Tax Provisions was $6.4 million in Q4 2024, with the low at -$882000.0 in Q3 2024.